Company Overview
Zhongchao Inc. operates within the Healthcare sector, specifically serving the Health Information Services industry by delivering healthcare information, education, and training services to healthcare professionals under its MDMOOC brand in the People's Republic of China. The company's operational model encompasses two distinct segments, focusing on MDMOOC services and the sales of patented drugs, while also offering patient management services. In terms of scale, the company maintains a market capitalization of $6.96M with an annual revenue of $13.12M and employs a workforce of 111 individuals. These financial metrics indicate that the company occupies a small-cap position in its market, characterized by a relatively modest revenue base that must be managed efficiently to sustain operations within the competitive health information landscape. The low market cap relative to its revenue suggests a niche operational focus rather than broad market dominance, while the employee count reflects a lean organizational structure typical of specialized service providers in this sector.
Financial Health
The company reported a revenue of $13.12M for the trailing twelve months, yet recorded a net income of $-1,698,530 and an EBITDA of $-875,820, revealing a significant gap between top-line generation and bottom-line profitability that points to substantial cost structures or operational inefficiencies. This negative net income and EBITDA indicate that current expenses, including cost of goods sold and operating expenses, are exceeding the revenue generated from MDMOOC services and patented drug sales. The company generated free cash flow of $-1,019,282, which signifies that cash outflows from operating activities and capital expenditures have exceeded cash inflows, thereby limiting immediate financial flexibility for discretionary spending or acquisitions. Despite these cash burn rates, the company holds a cash balance of $15.03M against total debt of $27,588, creating a robust liquidity buffer that supports its operational continuity. The debt-to-equity ratio stands at 0.12, indicating a highly conservative balance sheet where equity capital far exceeds debt obligations, minimizing financial leverage risk. Furthermore, the current ratio is 8.15, a figure that demonstrates exceptionally strong short-term liquidity and an abundant ability to cover current liabilities with available current assets. Return on Equity is recorded at -5.9% and Return on Assets at -2.9%, metrics that reveal that management effectiveness has been challenged by recent operational losses, resulting in a dilution of shareholder value and asset productivity during this period.
Valuation Assessment
The P/E Ratio (TTM) and Forward P/E are both listed as N/A, implying that the absence of positive earnings prevents the use of traditional earnings-based valuation multiples, which often necessitates reliance on alternative metrics for small-cap or loss-making entities. The price-to-book ratio is 0.28, a figure that indicates the company is trading at a significant discount to its book value, suggesting the market assigns low value to its tangible assets or anticipates future challenges in realizing that book value. Additionally, the price-to-sales ratio is 0.53, while the EV/EBITDA stands at 6.60, providing alternative perspectives that value the company based on revenue generation and enterprise value relative to cash flow, respectively, rather than current profitability. The stock's 52-week price range spans from a low of $1.44 to a high of $12.18, meaning the current valuation sits well below the recent peak but remains above the lowest trading point observed over the last year. The beta value is -0.03, a unique metric that suggests the stock's price volatility moves inversely to or independently of the broader market, presenting a distinct risk profile compared to typical equities that correlate positively with market movements.
Growth & Income
Revenue growth year-over-year has declined by -32.9%, while earnings growth is N/A due to the company's negative net income, indicating that the business is currently contracting in terms of top-line expansion rather than growing faster than its peers. The company does not distribute dividends, evidenced by a dividend yield of N/A and a payout ratio of 0.0%, which means the company reinvests its limited positive cash flows or retains cash reserves to fund operations rather than returning capital to shareholders. This lack of dividend income reflects a growth or survival strategy common among loss-making small-cap firms that prioritize retaining cash over paying distributions to investors. Overall, the company presents a profile characterized by revenue contraction and negative earnings, with no current income generation via dividends, requiring investors to rely on potential future turnaround scenarios for value realization.